Robeco Institutional Asset Management B.V. Acquires 92,168 Shares of Veeva Systems Inc. (NYSE:VEEV)

Robeco Institutional Asset Management B.V. increased its position in Veeva Systems Inc. (NYSE:VEEV - Free Report) by 27.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 427,565 shares of the technology company's stock after acquiring an additional 92,168 shares during the quarter. Robeco Institutional Asset Management B.V. owned about 0.26% of Veeva Systems worth $99,037,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of VEEV. ORG Partners LLC acquired a new stake in shares of Veeva Systems in the first quarter valued at about $26,000. Golden State Wealth Management LLC grew its holdings in Veeva Systems by 152.9% in the 1st quarter. Golden State Wealth Management LLC now owns 129 shares of the technology company's stock valued at $30,000 after buying an additional 78 shares during the last quarter. Smithfield Trust Co grew its holdings in Veeva Systems by 145.5% in the 4th quarter. Smithfield Trust Co now owns 135 shares of the technology company's stock valued at $27,000 after buying an additional 80 shares during the last quarter. Venturi Wealth Management LLC increased its position in Veeva Systems by 2,716.7% in the 4th quarter. Venturi Wealth Management LLC now owns 169 shares of the technology company's stock worth $36,000 after buying an additional 163 shares during the period. Finally, Promus Capital LLC acquired a new position in shares of Veeva Systems during the fourth quarter worth approximately $36,000. Institutional investors own 88.20% of the company's stock.

Veeva Systems Stock Up 0.7%

NYSE:VEEV traded up $1.90 on Thursday, reaching $281.40. The stock had a trading volume of 1,231,512 shares, compared to its average volume of 1,151,062. The company has a market capitalization of $45.98 billion, a P/E ratio of 59.62, a price-to-earnings-growth ratio of 2.19 and a beta of 0.99. Veeva Systems Inc. has a 1-year low of $177.41 and a 1-year high of $291.69. The stock has a fifty day moving average price of $252.45 and a 200-day moving average price of $235.03.

Veeva Systems (NYSE:VEEV - Get Free Report) last announced its earnings results on Wednesday, May 28th. The technology company reported $1.97 EPS for the quarter, topping the consensus estimate of $1.74 by $0.23. Veeva Systems had a return on equity of 13.96% and a net margin of 27.34%. The business had revenue of $759.04 million for the quarter, compared to the consensus estimate of $728.38 million. During the same period in the previous year, the business earned $1.50 EPS. Veeva Systems's revenue was up 16.7% compared to the same quarter last year. Sell-side analysts predict that Veeva Systems Inc. will post 4.35 earnings per share for the current fiscal year.

Insider Buying and Selling at Veeva Systems

In other Veeva Systems news, Director Timothy S. Cabral sold 3,882 shares of the company's stock in a transaction on Friday, April 4th. The stock was sold at an average price of $216.83, for a total transaction of $841,734.06. Following the transaction, the director now owns 5,500 shares of the company's stock, valued at approximately $1,192,565. This represents a 41.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Thomas D. Schwenger sold 1,200 shares of Veeva Systems stock in a transaction on Monday, April 14th. The shares were sold at an average price of $220.97, for a total value of $265,164.00. Following the completion of the sale, the insider now directly owns 25,889 shares of the company's stock, valued at $5,720,692.33. This trade represents a 4.43% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 6,184 shares of company stock worth $1,376,179. 10.30% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on VEEV shares. Wells Fargo & Company upped their target price on shares of Veeva Systems from $285.00 to $300.00 and gave the company an "overweight" rating in a research note on Thursday, May 29th. Stephens reaffirmed an "overweight" rating and set a $280.00 price objective on shares of Veeva Systems in a research report on Thursday, March 6th. KeyCorp reduced their target price on shares of Veeva Systems from $260.00 to $250.00 and set an "overweight" rating for the company in a research note on Wednesday, April 16th. Barclays boosted their price target on Veeva Systems from $285.00 to $300.00 and gave the company an "overweight" rating in a research note on Thursday, May 29th. Finally, UBS Group raised their price objective on Veeva Systems from $250.00 to $285.00 and gave the stock a "neutral" rating in a research report on Thursday, May 29th. Two analysts have rated the stock with a sell rating, eight have given a hold rating and sixteen have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $269.80.

Veeva Systems Company Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.